$2.430
-0.105 (-4.33%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de FATE por análisis de gráficos similares
Alphio's FATE stock price prediction model matches the current Fate Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $2.43 (+0.01%). The 1-week path is $2.45 (+0.98%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Fate Therapeutics Inc?
Fate Therapeutics Inc is a good buy right now due to its recent FDA clearance for the FT839 CAR T-cell product, which has the potential to significantly impact autoimmune disease treatment. The current price of $2.43 is well below the analyst price target of $4 from Jefferies and $7 from H.C. Wainwright, indicating substantial upside potential. Additionally, the stock has shown a year-to-date change of +146.35%, reflecting strong investor interest and confidence in its future prospects. However, the main risk is the negative earnings trend, with an EPS of -0.25 reported in the last quarter, which investors should monitor closely.
FATE cerró en $2.43 el Friday, tras bajar -4.33%
Fate Therapeutics Inc (FATE) last closed at $2.43, losing -4.33%. These facts feed the 1-day and 1-week FATE price prediction above.
Consenso de analistas
Fate Therapeutics Inc (FATE): 6 comprar, 0 mantener, 0 vender. Perspectiva: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Factores de la previsión
Los factores de la previsión de Fate Therapeutics Inc (FATE) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bullish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de FATE, ordenadas por similitud.
Análisis de estacionalidad de FATE
Historically the probability of a positive August return for FATE is 46.03%. February offers the highest probability of a positive month at 67.24%, while October is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de FATE
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Aug 2026 | $1.39 | $1.51 | $1.68 | -37.80% |
| Sep 2026 | $1.49 | $1.67 | $1.86 | -31.45% |
| Oct 2026 | $1.06 | $1.28 | $1.42 | -47.31% |
| Nov 2026 | $1.08 | $1.34 | $1.47 | -44.82% |
| Dec 2026 | $1.27 | $1.48 | $1.58 | -38.98% |
En 2026, se proyecta que Fate Therapeutics Inc (FATE) oscile entre $1.06 y $1.86.
Previsión mensual de Fate Therapeutics Inc para 2026
En Aug de 2026, se proyecta que Fate Therapeutics Inc promedie $1.51, con un mínimo de $1.39 y un máximo de $1.68.
En Sep de 2026, se proyecta que Fate Therapeutics Inc promedie $1.67, con un mínimo de $1.49 y un máximo de $1.86.
En Oct de 2026, se proyecta que Fate Therapeutics Inc promedie $1.28, con un mínimo de $1.06 y un máximo de $1.42.
En Nov de 2026, se proyecta que Fate Therapeutics Inc promedie $1.34, con un mínimo de $1.08 y un máximo de $1.47.
En Dec de 2026, se proyecta que Fate Therapeutics Inc promedie $1.48, con un mínimo de $1.27 y un máximo de $1.58.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.